[HTML][HTML] Predicting cancer immunotherapy response from gut microbiomes using machine learning models
H Liang, JH Jo, Z Zhang, MA MacGibeny, J Han… - Oncotarget, 2022 - ncbi.nlm.nih.gov
Cancer immunotherapy has significantly improved patient survival. Yet, half of patients do
not respond to immunotherapy. Gut microbiomes have been linked to clinical
responsiveness of melanoma patients on immunotherapies; however, different taxa have
been associated with response status with implicated taxa inconsistent between studies. We
used a tumor-agnostic approach to find common gut microbiome features of response
among immunotherapy patients with different advanced stage cancers. A combined meta …
not respond to immunotherapy. Gut microbiomes have been linked to clinical
responsiveness of melanoma patients on immunotherapies; however, different taxa have
been associated with response status with implicated taxa inconsistent between studies. We
used a tumor-agnostic approach to find common gut microbiome features of response
among immunotherapy patients with different advanced stage cancers. A combined meta …
以上显示的是最相近的搜索结果。 查看全部搜索结果